Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy in peritoneal carcinomatosis from ovarian cancer

<p>Abstract</p> <p>Background</p> <p>In selected patients with peritoneal carcinomatosis from ovarian cancer prognosis can be improved by cytoreductive surgery and hyperthermic intraperitoneal chemotherapy (HIPEC).</p> <p>Methods</p> <p>Between S...

وصف كامل

التفاصيل البيبلوغرافية
الحاوية / القاعدة:	World Journal of Surgical Oncology
المؤلفون الرئيسيون:	Loss Martin, Dahlke Marc-Hendrik, Piso Pompiliu, Schlitt Hans
التنسيق:	مقال
اللغة:	الإنجليزية
منشور في:	BMC 2004-06-01
الموضوعات:	peritoneal carcinomatosis ovarian cancer cytoreductive surgery intraperitoneal chemotherapy
الوصول للمادة أونلاين:	http://www.wjso.com/content/2/1/21

مواد مشابهة

Cytoreductive surgery with hyperthermic intraperitoneal chemotherapy in management of peritoneal carcinomatosis: Single center experience in Korea
حسب: Hee Ju Lee, وآخرون
منشور في: (2019-12-01)

The impact of hyperthermic intraperitoneal chemotherapy and cytoreductive surgery on clinical outcomes and quality of life of patients with peritoneal carcinomatosis
حسب: Oleksandr Vadymovych Bondar, وآخرون
منشور في: (2021-12-01)

Colorectal peritoneal carcinomatosis treated with cytoreductive surgery and hyperthermic intraperitoneal chemotherapy: The experience of a tertiary Asian center
حسب: Melissa Ching Ching Teo, وآخرون
منشور في: (2015-04-01)

Cytoreductive Surgery and Hyperthermic İntraperitoneal Chemoterapy for Advance Gastric Cancer Associated Peritoneal Carcinomatosis Single Centre Unit for 10 Consecutive Patients
حسب: Özgül Düzgün, وآخرون
منشور في: (2019-09-01)

EXPERIENCE IN APPLYING THE TECHNOLOGY OF CYTOREDUCTIVE SURGERY WITH HYPERTHERMIC INTRAOPERATIVE INTRAPERITONEAL CHEMOTHERAPY IN THE TREATMENT OF PATIENTS WITH PERITONEAL CARCINOMATOSIS
حسب: A. V. Shelekhov, وآخرون
منشور في: (2018-07-01)

Is cytoreductive surgery and hyperthermic intraperitoneal chemotherapy indicated in hepatobiliary malignancies?
حسب: Natasha Leigh, وآخرون
منشور في: (2020-06-01)

Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy outcomes in peritoneal carcinomatosis: 11-year tertiary-center experience
حسب: Burak Dinçer, وآخرون
منشور في: (2025-03-01)

Implementation of the enhanced recovery after surgery protocol for patients with peritoneal carcinomatosis undergoing cytoreductive surgery and hyperthermic intraperitoneal chemoperfusion
حسب: Oleksandr Ivanovych Tkachenko, وآخرون
منشور في: (2021-07-01)

Current clinical practices of cytoreductive surgery (CRS) and hyperthermic intraperitoneal chemotherapy (HIPEC)
حسب: Acs Miklos, وآخرون
منشور في: (2024-03-01)

Assessing morbidity, mortality, and survival in patients with peritoneal carcinomatosis undergoing cytoreductive surgery and hyperthermic intraperitoneal chemotherapy
حسب: JAIRO SEBASTIÁN ASTUDILLO VALLEJO, وآخرون
منشور في: (2023-04-01)

Factors Affecting Early Morbidity and Mortality in Patients with Complete Cytoreduction for Peritoneal Carcinomatosis
حسب: Erdal Bostanci, وآخرون
منشور في: (2022-09-01)

Outcome of Cytoreductive Surgery with HIPEC in Ovarian Versus Gastrointestinal Peritoneal Carcinomatosis: A 7-Year Single Centre Experience
حسب: Mohamed E Ramadan, وآخرون
منشور في: (2025-06-01)

Long-Term Outcomes following Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy for Peritoneal Carcinomatosis of Colorectal Origin
حسب: Kadhim Taqi, وآخرون
منشور في: (2024-06-01)

Cytoreductive surgery (CRS) and hyperthermic intraperitoneal chemotherapy (HIPEC) in small bowel adenocarcinoma with peritoneal metastasis: a systematic review
حسب: Chen Vicky, وآخرون
منشور في: (2022-11-01)

PERITONEAL CARCINOMATOSIS. REVIEW OF WORLD EXPERIENCE
حسب: S. V. Solomenny, وآخرون
منشور في: (2017-02-01)

Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for gastric cancer with peritoneal metastases at an Australian centre
حسب: Raymond Hayler, وآخرون
منشور في: (2025-03-01)

Peritoneal metastases from rare ovarian cancer treated with cytoreductive surgery and hyperthermic intraperitoneal chemotherapy (CRS/HIPEC)
حسب: Falla-Zuniga Luis Felipe, وآخرون
منشور في: (2023-12-01)

Tonic-Clonic Seizure following Cytoreductive Surgery with Intraperitoneal Oxaliplatin: A Case Report and Review of the Literature
حسب: Jessica Sayuri Tsukamoto, وآخرون
منشور في: (2016-02-01)

Efficacy and safety of cytoreductive surgery combined with hyperthermic intraperitoneal chemotherapy in patients with pancreatic cancer peritoneal metastasis
حسب: Guojun Yan, وآخرون
منشور في: (2024-09-01)

Cytoreductive surgery (CRS) and hyperthermic intraperitoneal chemotherapy (HIPEC) for children and young adults: experience from two high volume centers
حسب: Eckert Maximilian, وآخرون
منشور في: (2025-05-01)

Overall survival post secondary cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for recurrent colorectal cancer with peritoneal metastases
حسب: Raymond Hayler, وآخرون
منشور في: (2025-07-01)

Gastric cancer: modern approaches and prospects of treatment for peritoneal carcinomatosis (literature review)
حسب: V. A. Markovich, وآخرون
منشور في: (2022-01-01)

Advances in the Treatment of Colorectal Cancer with Peritoneal Metastases: A Focus on Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy
حسب: Youngbae Jeon, وآخرون
منشور في: (2023-12-01)

Early postoperative CRP predicts major complications following cytoreductive surgery (CRS) and hyperthermic intraperitoneal chemotherapy (HIPEC)
حسب: Kartik Akash, وآخرون
منشور في: (2023-06-01)

Outcomes and prognostic factors of cytoreductive surgery and perioperative intraperitoneal chemotherapy in high-volume peritoneal carcinomatosis
حسب: Lee S. Kyang, وآخرون
منشور في: (2022-12-01)

Pressurized intraperitoneal aerosolized chemotherapy clinical efficacy in the combined treatment of newly diagnosed ovarian cancer with peritoneal carcinomatosis and ascites
حسب: A. S. Dzasochov, وآخرون
منشور في: (2024-12-01)

Secondary cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for recurrent colorectal peritoneal metastases
حسب: Peter Harald Cashin, MD, PhD, وآخرون
منشور في: (2024-08-01)

Long-term survival outcomes following cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for peritoneal metastasis of hepatocellular carcinoma patients
حسب: Guojun Yan, وآخرون
منشور في: (2024-05-01)

Cytoreductive Surgery with Hyperthermic Intraperitoneal Chemotherapy for Colorectal Peritoneal Metastases Offers 60% Five-Year Overall Survival for Low-Volume Disease
حسب: Mina Guirgis, وآخرون
منشور في: (2025-08-01)

Durable Response after Repeat Cytoreductive Surgery (CRS) and Hyperthermic Intraperitoneal Chemotherapy (HIPEC) in a Patient with Extensive Mucinous Adenocarcinoma of the Appendix
حسب: Dalia Kaakour, وآخرون
منشور في: (2023-04-01)

Intraoperative photodynamic therapy and hyperthermic intraperitoneal chemotherapy in cytoreductive treatment of patients with disseminated mucinous carcinoma of appendix
حسب: D. V. Sidorov, وآخرون
منشور في: (2021-02-01)

Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy in the Management of Colorectal Cancer with Peritoneal Metastasis: A Single-Center Cohort Study
حسب: Fabrizio D’Acapito, وآخرون
منشور في: (2024-06-01)

Perspectives of pressurized intraperitoneal aerosol chemotherapy in terms of primary ovarian cancer with peritoneal carcinomatosis treatment
حسب: A. S. Dzasokhov, وآخرون
منشور في: (2023-03-01)

Management and Outcomes of Urinary Tract Involvement in Cytoreductive Surgery with Hyperthermic Intraperitoneal Chemotherapy (CRS/HIPEC): A Retrospective Cohort Study
حسب: Feza Karakayali, وآخرون
منشور في: (2025-07-01)

Combined modality treatment of patients with stage IV gastric cancer with peritoneal carcinomatosis
حسب: V. A. Markovich, وآخرون
منشور في: (2023-02-01)

Peritoneal Carcinomatosis: Current State of the Art and Schools of Thought
حسب: Sh. Kh. Gantsev, وآخرون
منشور في: (2021-04-01)

Real-world risk factors for incomplete cytoreduction in peritoneal carcinomatosis patients scheduled for cytoreductive surgery and hyperthermic intraperitoneal chemotherapy
حسب: Chao-Yu Chen, وآخرون
منشور في: (2025-09-01)

Anesthetic management of cytoreductive surgery and hyperthermic intraperitoneal chemotherapy: A case series
حسب: Aswini Lakshminarasimhan, وآخرون
منشور في: (2025-11-01)

The Impact of Computed Tomography Measurements of Sarcopenia on Postoperative and Oncologic Outcomes in Patients Undergoing Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy
حسب: Maher Al Khaldi, وآخرون
منشور في: (2022-11-01)

Current practices of cytoreductive surgery and hyperthermic intraperitoneal chemotherapy in the treatment of peritoneal surface malignancies: an international survey of oncologic surgeons
حسب: Heon Jong Yoo, وآخرون
منشور في: (2018-05-01)